NRx Pharmaceuticals Ownership | Who Owns NRx Pharmaceuticals?
NRx Pharmaceuticals Ownership Summary
NRx Pharmaceuticals is owned by 5.36% institutional investors, 11.55% insiders, and 83.09% retail investors. Anson funds management lp is the largest institutional shareholder, holding 11.29% of NRXP shares. AdvisorShares Psychedelics ETF is the top mutual fund, with 1.36% of its assets in NRx Pharmaceuticals shares.
NRXP Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | NRx Pharmaceuticals | 5.36% | 11.55% | 83.09% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Anson funds management lp | 2.03M | 11.29% | $6.68M |
| Vanguard group | 534.96K | 2.98% | $1.77M |
| Advisorshares investments | 342.14K | 1.91% | $1.13M |
| Marshall wace, llp | 189.14K | 1.05% | $624.15K |
| Geode capital management | 185.86K | 1.04% | $613.46K |
| Ubs group | 152.85K | 0.85% | $504.40K |
| Renaissance | 128.18K | 0.71% | $422.98K |
| State street | 76.28K | 0.43% | $251.74K |
| Jane street group | 73.40K | 0.41% | $242.22M |
| Blackrock funding, inc. /de | 65.41K | 0.36% | $215.86K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Anson funds management lp | 2.03M | 0.61% | $6.68M |
| Advisorshares investments | 342.14K | 0.18% | $1.13M |
| One wealth management investment & advisory services | 27.99K | 0.11% | $92.37K |
| Chicago partners investment group | 41.99K | 0.00% | $125.98K |
| Ethos financial group | 11.90K | 0.00% | $39.27K |
| Renaissance | 128.18K | 0.00% | $422.98K |
| Marshall wace, llp | 189.14K | 0.00% | $624.15K |
| Two sigma investments, lp | 52.33K | 0.00% | $172.70K |
| Sbi securities | 2.50K | 0.00% | $8.25K |
| Carolina wealth advisors | 50.00 | 0.00% | $165.00 |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Anson funds management lp | 2.03M | 0.61% | 420.13K |
| Marshall wace, llp | 189.14K | 0.00% | 155.75K |
| Renaissance | 128.18K | 0.00% | 128.18K |
| Vanguard group | 534.96K | - | 82.78K |
| Advisorshares investments | 342.14K | 0.18% | 78.34K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Squarepoint ops | - | - | -42.20K |
| Townsquare capital | - | - | -15.04K |
| Group one trading | - | - | -3.11K |
| Raymond james financial | - | - | -2.57K |
| Sbi securities | 2.50K | 0.00% | -892.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Renaissance | 128.18K | 0.00% | 128.18K | $422.98K |
| Jane street group | 73.40K | - | 73.40K | $242.22M |
| Chicago partners investment group | 41.99K | 0.00% | 41.99K | $125.98K |
| Ethos financial group | 11.90K | 0.00% | 11.90K | $39.27K |
Sold Out
| Holder | Change |
|---|---|
| Simplex trading | -690.00 |
| Raymond james financial | -2.57K |
| Group one trading | -3.11K |
| Townsquare capital | -15.04K |
| Squarepoint ops | -42.20K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 8 | -65.22% | 961,561 | -66.82% | 5 | 1.72% | 5 | -64.29% | 1 | -66.67% |
| Jun 30, 2025 | 25 | 8.70% | 2,994,368 | 32.46% | 18 | 9.62% | 15 | 50.00% | 4 | -33.33% |
| Mar 31, 2025 | 23 | -14.81% | 2,260,524 | 115.57% | 13 | 13.86% | 10 | -37.50% | 6 | 200.00% |
| Dec 31, 2024 | 27 | 28.57% | 1,048,642 | 46.80% | 9 | 23.53% | 16 | 77.78% | 2 | -50.00% |
| Sep 30, 2024 | 21 | - | 714,327 | 39.97% | 6 | 27.64% | 9 | 80.00% | 4 | -73.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| AdvisorShares Psychedelics ETF | 323.15K | 1.36% | - |
| Vanguard Total Stock Mkt Idx Inv | 246.38K | 1.26% | -5.38K |
| Vanguard US Total Market Shares ETF | 193.42K | 1.23% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 144.48K | 0.74% | -41.40K |
| Fidelity Extended Market Index | 74.11K | 0.31% | -609.00 |
| KoAct US Brain Treatment Active | 41.02K | 0.26% | 41.02K |
| iShares Micro-Cap ETF | 32.09K | 0.14% | - |
| Fidelity Total Market Index | 31.03K | 0.13% | -66.00 |
| Spartan Extended Market Index Pool E | 14.99K | 0.10% | 6.13K |
| Fidelity Nasdaq Composite Index | 21.98K | 0.09% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 17, 2024 | Javitt Jonathan C | Chairman and Chief Scientist | Buy | $46.80K |
| Aug 30, 2023 | Gorovitz Aaron | - | Buy | $11.20K |
| Aug 30, 2023 | Hurvitz Chaim | - | Buy | $20.13K |
| Aug 23, 2023 | Javitt Jonathan C | Chief Scientist | Buy | $33.00K |
| Aug 22, 2023 | Javitt Jonathan C | Chief Scientist | Buy | $64.40K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 1 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q4 | - | - |
| 2023 Q3 | 4 | - |
NRXP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools